The Committee on Clinical Pharmacology and Pharmacogenomics at the University of Chicago, chaired by M. Eileen Dolan, PhD, is seeking motivated trainees for our clinical pharmacology and pharmacogenomics fellowship training program.
The NIH NIGMS/NICHD funded program is open to those interested in personalized medicine, pharmacogenomics, new drug development, clinical pharmacology, clinical trial design, genetics of drug abuse and/or clinical trial design.
Our two-year American Board of Clinical Pharmacology (ABCP) accredited program is a multidisciplinary, comprehensive and collaborative initiative that emphasizes individual creativity in the context of an encouraging environment. Trainees will have the opportunity to tailor their work to emphasize clinical, translational or basic science research spending protected time devoted their research efforts with the remainder dedicated to core curriculum, clinical activities and required rotations (as applicable). After successful completion, trainees are eligible to become board certified in Clinical Pharmacology.
Additional Salary Information: Yearly stipend is paid per 2020 NIH guidelines. Health insurance is provided as well as optional dental and vision. Funds are provided to each trainee for training related expenses and travel.
Internal Number: N/A
About University of Chicago Clinical Therapeutics Training Program
The postdoctoral training program in Clinical Therapeutics is the core function of the Committee on Clinical Pharmacology and Pharmacogenomics at The University of Chicago and the educational and training component within the Center for Personalized Therapeutics. The program provides an infrastructure for the postdoctoral training of both clinicians and translational scientists in clinical pharmacology, therapeutics, and pharmacogenomics.